Zacks Investment Research Downgrades Immuron Limited – American Depositary Shares (IMRN) to Hold

Zacks Investment Research lowered shares of Immuron Limited – American Depositary Shares (NASDAQ:IMRN) from a buy rating to a hold rating in a research note released on Wednesday morning.

According to Zacks, “Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale, Australia. “

How to Become a New Pot Stock Millionaire

Several other equities analysts also recently issued reports on IMRN. ValuEngine downgraded shares of Immuron Limited – American Depositary Shares from a buy rating to a hold rating in a report on Monday, April 2nd. HC Wainwright reissued a buy rating and set a $20.00 price target on shares of Immuron Limited – American Depositary Shares in a report on Friday, March 9th.

Shares of IMRN opened at $11.35 on Wednesday. Immuron Limited – American Depositary Shares has a 1 year low of $4.47 and a 1 year high of $16.70.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/04/08/zacks-investment-research-downgrades-immuron-limited-american-depositary-shares-imrn-to-hold.html.

Immuron Limited – American Depositary Shares Company Profile

Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle.

Get a free copy of the Zacks research report on Immuron Limited – American Depositary Shares (IMRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Immuron Limited - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immuron Limited - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply